| Insider | Cuffe Michael S. |
|---|---|
| Title | EVP and Chief Clinical Officer |
| Transaction Date | Feb 10, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 10, 2026 |
| Shares Purchased | 9,628 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 35,581 |
| Derivative | No |
| Accession Number | 0001193125-26-049186 |
| Document | View SEC Filing |